Oramed Pharmaceuticals Inc. (ORMP) stock
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.71−0.32 (-7.94%)
Close on Nov 13, 2026Market cap $154.33MP/E 1.1Yield 6.74%
Oramed Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Oramed Pharmaceuticals's operating margin for the twelve months ending Dec 31, 2025 was -754.4%. For fiscal 2025 it was -754.4%, against -1176.8% the year before. The highest annual figure on record is -433.8% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -754.4% | +422.4 |
| FY2023 | Dec 31, 2023 | -1176.8% | −280.6 |
| FY2021 | Aug 31, 2021 | -896.2% | −462.3 |
| FY2020 | Aug 31, 2020 | -433.8% | +107.4 |
| FY2019 | Aug 31, 2019 | -541.3% | +11.1 |
| FY2018 | Aug 31, 2018 | -552.3% | −113.8 |
| FY2017 | Aug 31, 2017 | -438.6% | +1123.1 |
| FY2016 | Aug 31, 2016 | -1561.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -225.0% | +673.4 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -562.5% | +169.6 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -782.0% | +82.6 |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | -1084.9% | −641.9 |
| Q3 FY2021CQ2 2021 | May 31, 2021 | -898.4% | −564.5 |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | -732.0% | −133.1 |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | -864.5% | −504.2 |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | -443.0% | −98.7 |
| Q3 FY2020CQ2 2020 | May 31, 2020 | -333.9% | +264.0 |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | -599.0% | −88.4 |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | -360.4% | +374.5 |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | -344.3% | +170.7 |
| Q3 FY2019CQ2 2019 | May 31, 2019 | -597.9% | −150.8 |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | -510.5% | −48.9 |
| Q3 FY2018CQ2 2018 | May 31, 2018 | -734.8% | −385.6 |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | -515.1% | +35.7 |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | -447.1% | −54.0 |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | -461.7% | +1312.4 |
| Q3 FY2017CQ2 2017 | May 31, 2017 | -349.3% | +1180.3 |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | -550.7% | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | -393.1% | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | -1774.1% | – |
| Q2 FY2016CQ1 2016 | Feb 29, 2016 | -1529.6% | – |
See a number that looks wrong?